Newbridge Financial Services Group’s Mereo BioPharma MREO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $35.2K | Buy |
13,000
+2,000
| +18% | +$5.42K | 0.01% | 578 |
|
|
2025
Q1 | $24.8K | Buy |
11,000
+300
| +3% | +$675 | 0.01% | 499 |
|
|
2024
Q4 | $37.5K | Buy |
+10,700
| New | +$37.5K | 0.01% | 472 |
|
|
2024
Q3 | – | Sell |
-11,700
| Closed | -$42.1K | – | 940 |
|
|
2024
Q2 | $42.1K | Hold |
11,700
| – | – | 0.02% | 406 |
|
|
2024
Q1 | $38.6K | Buy |
11,700
+2,200
| +23% | +$7.26K | 0.02% | 449 |
|
|
2023
Q4 | $21.9K | Buy |
+9,500
| New | +$21.9K | 0.01% | 574 |
|
|
2023
Q3 | – | Sell |
-9,500
| Closed | -$12.5K | – | 1370 |
|
|
2023
Q2 | $12.5K | Buy |
9,500
+2,500
| +36% | +$3.3K | 0.01% | 836 |
|
|
2023
Q1 | $4.95K | Buy |
7,000
+3,000
| +75% | +$2.12K | ﹤0.01% | 1072 |
|
|
2022
Q4 | $3K | Hold |
4,000
| – | – | ﹤0.01% | 1154 |
|
|
2022
Q3 | $3K | Hold |
4,000
| – | – | ﹤0.01% | 1138 |
|
|
2022
Q2 | $4K | Hold |
4,000
| – | – | ﹤0.01% | 1059 |
|
|
2022
Q1 | $4K | Hold |
4,000
| – | – | ﹤0.01% | 1149 |
|
|
2021
Q4 | $6K | Hold |
4,000
| – | – | ﹤0.01% | 1034 |
|
|
2021
Q3 | $10K | Hold |
4,000
| – | – | 0.01% | 870 |
|
|
2021
Q2 | $13K | Hold |
4,000
| – | – | 0.01% | 910 |
|
|
2021
Q1 | $13K | Buy |
+4,000
| New | +$13K | 0.01% | 824 |
|